Co-occurring Opioid and Stimulant Use Disorders: Treatment and Management Approaches

Sponsor: Providers Clinical Support System

Description:

People who use opioids and stimulants concurrently have over twice the risk of fatal overdose compared to individuals who use opioids only, according to a 2022 study. Despite the increased risk of overdose bolstered by the ever-changing and adulterated drug supply, research indicates a lack of training that specifically addresses treating and managing co-occurring opioid and stimulant use disorders.

While medication for opioid use disorder (MOUD) is the gold standard for treating OUD, there are no FDA-approved medications to treat stimulant use disorder, though behavioral therapies like contingency management have been well-studied. These challenges highlight the need to identify promising treatment strategies to ensure individuals with co-occurring opioid and stimulant use disorders are effectively engaged in care to prevent overdose.

This session will equip behavioral health treatment providers and organizations with the tools necessary to effectively engage and provide quality, team-based care and services to clients with co-occurring opioid and stimulant use disorders to improve health outcomes, reduce overdose risk and support long-term recovery.

The webinar will:
• Describe the broad context of co-occurring opioid and stimulant use and overdose risk in the U.S.
• Review evidence-based strategies to treat OUD and promising practices for stimulant use.
• Identify evidence-based and promising strategies to treat co-occurring opioid and stimulant use disorders.
• Review psychiatric co-morbidities associated with opioid and stimulant use disorders.

Funding for this initiative was made possible (in part) by grant no. 6H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

For more information and to register click here:

Event Details